We hypothesized that TP53 codon 72 polymorphism could affect somatic mutations during bladder carcinogenesis and conducted this study to compare germline TP53 codon 72 polymorphism and somatic mutations in bladder cancer. The gene discussed is TP53; the disease is urinary bladder carcinoma.